Feasibility of dynamic contrast enhanced MRI using low dose Gadolinium: Comparative performance with standard dose in prostate cancer diagnosis

OBJECTIVES: This study investigates whether administration of low doses of Gadolinium-based contrast agent (GBCA) for dynamic contrast enhanced (DCE) MRI can be as effective as a standard dose in distinguishing prostate cancer (PCa) from benign tissue. In addition, we evaluated the combination of ki...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Invest Radiol
Hlavní autoři: He, Dianning, Chatterjee, Aritrick, Fan, Xiaobing, Wang, Shiyang, Eggener, Scott, Yousuf, Ambereen, Antic, Tatjana, Oto, Aytekin, Karczmar, Gregory S.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6512866/
https://ncbi.nlm.nih.gov/pubmed/29702525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/RLI.0000000000000466
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky